RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions.


Journal

Nature immunology
ISSN: 1529-2916
Titre abrégé: Nat Immunol
Pays: United States
ID NLM: 100941354

Informations de publication

Date de publication:
12 2019
Historique:
received: 19 12 2018
accepted: 26 09 2019
pubmed: 20 11 2019
medline: 28 2 2020
entrez: 20 11 2019
Statut: ppublish

Résumé

The initial response to viral infection is anticipatory, with host antiviral restriction factors and pathogen sensors constantly surveying the cell to rapidly mount an antiviral response through the synthesis and downstream activity of interferons. After pathogen clearance, the host's ability to resolve this antiviral response and return to homeostasis is critical. Here, we found that isoforms of the RNA-binding protein ZAP functioned as both a direct antiviral restriction factor and an interferon-resolution factor. The short isoform of ZAP bound to and mediated the degradation of several host interferon messenger RNAs, and thus acted as a negative feedback regulator of the interferon response. In contrast, the long isoform of ZAP had antiviral functions and did not regulate interferon. The two isoforms contained identical RNA-targeting domains, but differences in their intracellular localization modulated specificity for host versus viral RNA, which resulted in disparate effects on viral replication during the innate immune response.

Identifiants

pubmed: 31740798
doi: 10.1038/s41590-019-0527-6
pii: 10.1038/s41590-019-0527-6
pmc: PMC7240801
mid: NIHMS1586922
doi:

Substances chimiques

IRF3 protein, human 0
Interferon Regulatory Factor-3 0
Protein Isoforms 0
RNA, Small Interfering 0
RNA-Binding Proteins 0
Repressor Proteins 0
YLPM1 protein, human 0
RNA 63231-63-0
Interferons 9008-11-1

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1610-1620

Subventions

Organisme : NIAID NIH HHS
ID : R01 AI108765
Pays : United States
Organisme : NIGMS NIH HHS
ID : R35 GM133633
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI118916
Pays : United States
Organisme : NIAID NIH HHS
ID : R21 AI135437
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007240
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM007270
Pays : United States
Organisme : NIAID NIH HHS
ID : K22 AI119017
Pays : United States
Organisme : NIAID NIH HHS
ID : T32 AI106677
Pays : United States
Organisme : NIH HHS
ID : S10 OD021490
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM069429
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI127463
Pays : United States
Organisme : NIAID NIH HHS
ID : R01 AI104002
Pays : United States

Références

Schoggins, J. W. et al. A diverse range of gene products are effectors of the type I interferon antiviral response. Nature 472, 481–485 (2011).
pubmed: 21478870 pmcid: 3409588 doi: 10.1038/nature09907
Harris, R. S. & Dudley, J. P. APOBECs and virus restriction. Virology 479-480, 131–145 (2015).
pubmed: 25818029 doi: 10.1016/j.virol.2015.03.012
Haller, O., Staeheli, P., Schwemmle, M. & Kochs, G. Mx GTPases: dynamin-like antiviral machines of innate immunity. Trends Microbiol. 23, 154–163 (2015).
pubmed: 25572883 doi: 10.1016/j.tim.2014.12.003
Diamond, M. S. & Farzan, M. The broad-spectrum antiviral functions of IFIT and IFITM proteins. Nat. Rev. Immunol. 13, 46–57 (2013).
pubmed: 23237964 doi: 10.1038/nri3344
Jarret, A. et al. Hepatitis-C-virus-induced microRNAs dampen interferon-mediated antiviral signaling. Nat. Med. 22, 1475–1481 (2016).
pubmed: 27841874 pmcid: 5551900 doi: 10.1038/nm.4211
McFarland, A. P. et al. The favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs. Nat. Immunol. 15, 72–79 (2014).
pubmed: 24241692 doi: 10.1038/ni.2758
Savan, R. Post-transcriptional regulation of interferons and their signaling pathways. J. Interferon Cytokine Res. 34, 318–329 (2014).
pubmed: 24702117 pmcid: 4015472 doi: 10.1089/jir.2013.0117
Schwerk, J. & Savan, R. Translating the untranslated region. J. Immunol. 195, 2963–2971 (2015).
pubmed: 26386038 doi: 10.4049/jimmunol.1500756
Bick, M. J. et al. Expression of the zinc-finger antiviral protein inhibits alphavirus replication. J. Virol. 77, 11555–11562 (2003).
pubmed: 14557641 pmcid: 229374 doi: 10.1128/JVI.77.21.11555-11562.2003
Gao, G., Guo, X. & Goff, S. P. Inhibition of retroviral RNA production by ZAP, a CCCH-type zinc finger protein. Science 297, 1703–1706 (2002).
pubmed: 12215647 doi: 10.1126/science.1074276
Muller, S. et al. Inhibition of filovirus replication by the zinc finger antiviral protein. J. Virol. 81, 2391–2400 (2007).
pubmed: 17182693 doi: 10.1128/JVI.01601-06
Zhu, Y. et al. Zinc-finger antiviral protein inhibits HIV-1 infection by selectively targeting multiply spliced viral mRNAs for degradation. Proc. Natl Acad. Sci. USA 108, 15834–15839 (2011).
pubmed: 21876179 pmcid: 3179061 doi: 10.1073/pnas.1101676108
Guo, X., Carroll, J. W., Macdonald, M. R., Goff, S. P. & Gao, G. The zinc finger antiviral protein directly binds to specific viral mRNAs through the CCCH zinc finger motifs. J. Virol. 78, 12781–12787 (2004).
pubmed: 15542630 pmcid: 525010 doi: 10.1128/JVI.78.23.12781-12787.2004
Guo, X., Ma, J., Sun, J. & Gao, G. The zinc-finger antiviral protein recruits the RNA processing exosome to degrade the target mRNA. Proc. Natl Acad. Sci. USA 104, 151–156 (2007).
pubmed: 17185417 doi: 10.1073/pnas.0607063104
Kerns, J. A., Emerman, M. & Malik, H. S. Positive selection and increased antiviral activity associated with the PARP-containing isoform of human zinc-finger antiviral protein. PLoS Genet. 4, e21 (2008).
pubmed: 18225958 pmcid: 2213710 doi: 10.1371/journal.pgen.0040021
Vyas, S., Chesarone-Cataldo, M., Todorova, T., Huang, Y. H. & Chang, P. A systematic analysis of the PARP protein family identifies new functions critical for cell physiology. Nat. Commun. 4, 2240 (2013).
pubmed: 23917125 doi: 10.1038/ncomms3240
Hayakawa, S. et al. ZAPS is a potent stimulator of signaling mediated by the RNA helicase RIG-I during antiviral responses. Nat. Immunol. 12, 37–44 (2011).
pubmed: 21102435 doi: 10.1038/ni.1963
Ryman, K. D. et al. Sindbis virus translation is inhibited by a PKR/RNase L-independent effector induced by alpha/beta interferon priming of dendritic cells. J. Virol. 79, 1487–1499 (2005).
pubmed: 15650175 pmcid: 544143 doi: 10.1128/JVI.79.3.1487-1499.2005
Wang, N. et al. Viral induction of the zinc finger antiviral protein is IRF3-dependent but NF-κB-independent. J. Biol. Chem. 285, 6080–6090 (2010).
pubmed: 20048147 pmcid: 2825402 doi: 10.1074/jbc.M109.054486
Takagaki, Y., Seipelt, R. L., Peterson, M. L. & Manley, J. L. The polyadenylation factor CstF-64 regulates alternative processing of IgM heavy chain pre-mRNA during B cell differentiation. Cell 87, 941–952 (1996).
pubmed: 8945520 doi: 10.1016/S0092-8674(00)82000-0
Chuvpilo, S. et al. Alternative polyadenylation events contribute to the induction of NF-ATc in effector T cells. Immunity 10, 261–269 (1999).
pubmed: 10072078 doi: 10.1016/S1074-7613(00)80026-6
Shell, S. A., Hesse, C., Morris, S. M. Jr. & Milcarek, C. Elevated levels of the 64-kDa cleavage stimulatory factor (CstF-64) in lipopolysaccharide-stimulated macrophages influence gene expression and induce alternative poly(A) site selection. J. Biol. Chem. 280, 39950–39961 (2005).
pubmed: 16207706 doi: 10.1074/jbc.M508848200
Lee, H. et al. Zinc-finger antiviral protein mediates retinoic acid inducible gene I-like receptor-independent antiviral response to murine leukemia virus. Proc. Natl Acad. Sci. USA 110, 12379–12384 (2013).
pubmed: 23836649 pmcid: 3725099 doi: 10.1073/pnas.1310604110
Charron, G., Li, M. M., MacDonald, M. R. & Hang, H. C. Prenylome profiling reveals S-farnesylation is crucial for membrane targeting and antiviral activity of ZAP long-isoform. Proc. Natl Acad. Sci. USA 110, 11085–11090 (2013).
pubmed: 23776219 pmcid: 3703996 doi: 10.1073/pnas.1302564110
Wang, M. & Casey, P. J. Protein prenylation: unique fats make their mark on biology. Nat. Rev. Mol. Cell Biol. 17, 110–122 (2016).
pubmed: 26790532 doi: 10.1038/nrm.2015.11
Gustafsson, M. G. Surpassing the lateral resolution limit by a factor of two using structured illumination microscopy. J. Microsc. 198, 82–87 (2000).
pubmed: 10810003 doi: 10.1046/j.1365-2818.2000.00710.x
Zhang, Y., Burke, C. W., Ryman, K. D. & Klimstra, W. B. Identification and characterization of interferon-induced proteins that inhibit alphavirus replication. J. Virol. 81, 11246–11255 (2007).
pubmed: 17686841 pmcid: 2045553 doi: 10.1128/JVI.01282-07
Kujala, P. et al. Biogenesis of the Semliki Forest virus RNA replication complex. J. Virol. 75, 3873–3884 (2001).
pubmed: 11264376 pmcid: 114878 doi: 10.1128/JVI.75.8.3873-3884.2001
DiCiommo, D. P. & Bremner, R. Rapid, high level protein production using DNA-based Semliki Forest virus vectors. J. Biol. Chem. 273, 18060–18066 (1998).
pubmed: 9660762 doi: 10.1074/jbc.273.29.18060
Chiu, H. P. et al. Inhibition of Japanese encephalitis virus infection by the host zinc-finger antiviral protein. PLoS Pathog. 14, e1007166 (2018).
pubmed: 30016363 pmcid: 6049953 doi: 10.1371/journal.ppat.1007166
Zhu, Y. & Gao, G. ZAP-mediated mRNA degradation. RNA Biol. 5, 65–67 (2008).
pubmed: 18418085 doi: 10.4161/rna.5.2.6044
Zhu, Y., Wang, X., Goff, S. P. & Gao, G. Translational repression precedes and is required for ZAP-mediated mRNA decay. EMBO J. 31, 4236–4246 (2012).
pubmed: 23023399 pmcid: 3492732 doi: 10.1038/emboj.2012.271
Rosengren, A. T., Nyman, T. A., Syyrakki, S., Matikainen, S. & Lahesmaa, R. Proteomic and transcriptomic characterization of interferon-α-induced human primary T helper cells. Proteomics 5, 371–379 (2005).
pubmed: 15700245 doi: 10.1002/pmic.200400967
Huang, Z., Wang, X. & Gao, G. Analyses of SELEX-derived ZAP-binding RNA aptamers suggest that the binding specificity is determined by both structure and sequence of the RNA. Protein Cell 1, 752–759 (2010).
pubmed: 21203916 pmcid: 4875198 doi: 10.1007/s13238-010-0096-9
Takata, M. A. et al. CG dinucleotide suppression enables antiviral defence targeting non-self RNA. Nature 550, 124–127 (2017).
pubmed: 28953888 pmcid: 6592701 doi: 10.1038/nature24039
Chen, S. et al. Structure of N-terminal domain of ZAP indicates how a zinc-finger protein recognizes complex RNA. Nat. Struct. Mol. Biol. 19, 430–435 (2012).
pubmed: 22407013 doi: 10.1038/nsmb.2243
Glasker, S., Toller, M. & Kummerer, B. M. The alternate triad motif of the poly(ADP-ribose) polymerase-like domain of the human zinc finger antiviral protein is essential for its antiviral activity. J. Gen. Virol. 95, 816–822 (2014).
pubmed: 24457973 doi: 10.1099/vir.0.060988-0
Liu, C. H., Zhou, L., Chen, G. & Krug, R. M. Battle between influenza A virus and a newly identified antiviral activity of the PARP-containing ZAPL protein. Proc. Natl Acad. Sci. USA 112, 14048–14053 (2015).
pubmed: 26504237 pmcid: 4653199 doi: 10.1073/pnas.1509745112
Wang, X. L. et al. Sindbis virus can exploit a host antiviral protein to evade immune surveillance. J. Virol. 90, 10247–10258 (2016).
pubmed: 27581990 pmcid: 5105660 doi: 10.1128/JVI.01487-16
Saito, T., Owen, D. M., Jiang, F., Marcotrigiano, J. & Gale, M. Jr. Innate immunity induced by composition-dependent RIG-I recognition of hepatitis C virus RNA. Nature 454, 523–527 (2008).
pubmed: 18548002 pmcid: 2856441 doi: 10.1038/nature07106
Urban, T. J. et al. IL28B genotype is associated with differential expression of intrahepatic interferon-stimulated genes in patients with chronic hepatitis C. Hepatology 52, 1888–1896 (2010).
pubmed: 20931559 doi: 10.1002/hep.23912
Friedman, J. R., Webster, B. M., Mastronarde, D. N., Verhey, K. J. & Voeltz, G. K. ER sliding dynamics and ER-mitochondrial contacts occur on acetylated microtubules. J. Cell Biol. 190, 363–375 (2010).
pubmed: 20696706 pmcid: 2922647 doi: 10.1083/jcb.200911024
Rowland, A. A., Chitwood, P. J., Phillips, M. J. & Voeltz, G. K. ER contact sites define the position and timing of endosome fission. Cell 159, 1027–1041 (2014).
pubmed: 25416943 pmcid: 4634643 doi: 10.1016/j.cell.2014.10.023
Olenych, S. G., Claxton, N. S., Ottenberg, G. K. & Davidson, M. W. The fluorescent protein color palette. Curr. Protoc. Cell Biol. 33, 21.5.25 (2006).
doi: 10.1002/0471143030.cb2105s33
Vogt, D. A. & Ott, M. Membrane flotation assay. Bio Protoc. 5, e1435 (2015).
pubmed: 27540564 doi: 10.21769/BioProtoc.1435
Boritz, E., Gerlach, J., Johnson, J. E. & Rose, J. K. Replication-competent rhabdoviruses with human immunodeficiency virus type 1 coats and green fluorescent protein: entry by a pH-independent pathway. J. Virol. 73, 6937–6945 (1999).
pubmed: 10400792 pmcid: 112779 doi: 10.1128/JVI.73.8.6937-6945.1999

Auteurs

Johannes Schwerk (J)

Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.

Frank W Soveg (FW)

Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.

Andrew P Ryan (AP)

Section of Molecular Biology, Division of Biological Sciences, University of California San Diego, La Jolla, CA, USA.

Kerri R Thomas (KR)

Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.

Lauren D Hatfield (LD)

Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.

Snehal Ozarkar (S)

Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.

Adriana Forero (A)

Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.

Alison M Kell (AM)

Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.

Justin A Roby (JA)

Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.

Lomon So (L)

Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.
Immunology Program, Benaroya Research Institute at Virginia Mason, Seattle, WA, USA.

Jennifer L Hyde (JL)

Department of Microbiology, School of Medicine, University of Washington, Seattle, WA, USA.

Michael Gale (M)

Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA.
Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA, USA.

Matthew D Daugherty (MD)

Section of Molecular Biology, Division of Biological Sciences, University of California San Diego, La Jolla, CA, USA. mddaugherty@ucsd.edu.

Ram Savan (R)

Department of Immunology, School of Medicine, University of Washington, Seattle, WA, USA. savanram@uw.edu.
Center for Innate Immunity and Immune Disease, University of Washington, Seattle, WA, USA. savanram@uw.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH